📰 Matt Pullen News
Page 2 - Matt Pullen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Matt Pullen. Real-time updates on events, politics, business and more.
April 5, 2023
Genuit Group Martin Gisbourne to lead company's sustainability journey
April 5, 2023
FTSE 100 Rises as Utilities Gain; RS Group Falls 0815 GMT - The FTSE 100 Index gains 0.3%, or 19 points to 7653 as gains for utility and drug stocks offset losses for RS Group and industrial shares. United Utilities, Centrica, Severn Trent and Nati... | 04:40am
April 5, 2023
UK Gilt Yields Rise After Above-Forecast UK Services PMI Data 1036 GMT - Gilt yields rise after U.K. services PMI data in March came in stronger than expected, adding to prospects of further interest-rate rises by the Bank of England. The S&P G... | 06:57am
April 5, 2023
Sterling May Fall Vs Euro as BOE Rate Rise Bets Overdone 0843 GMT - Sterling looks set to weaken against the euro this year as interest-rate expectations for the Bank of England look overdone, ING says. While GBP/USD should be supported in the ver... | 05:03am
April 5, 2023
The FTSE 100 index ended the session 0.37% higher on Wednesday as sharp losses for electronics distributor RS Group, Irish building-materials supplier CRH and home-improvement retailer Kingfisher were offset by gains of defensive stocks. "It's been a b... | 12:11pm
April 5, 2023
Sterling Unlikely to Fall Materially if BOE Pauses Rate Rise Cycle 1042 GMT - The Bank of England is likely to pause its cycle of interest-rate rises in May but this won't materially weaken sterling, Monex Europe says. Markets are pricing in just ... | 08:30am
December 8, 2022
City firefighters have begun packing toys for an estimated 700-plus Owen Sound kids for Christmas.
November 28, 2022
Investegate announcements from Genuit Group PLC, Director/PDMR Shareholding
November 9, 2022
Investegate announcements from Genuit Group PLC, Director/PDMR Shareholding
October 18, 2022
UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system's responses to Alzheimer's disease and multiple sclerosis (MS), potentially allowing doctors to supercharge the body's ability to fight those and other devastating neurological diseases.